Muyi Yang

Chinese PLA General Hospital

Papers

1

Total Citations

14

H-Index

1

About

Dr. Muyi Yang is a pioneering hepatobiliary surgeon whose research focuses on advancing minimally invasive surgical techniques for liver cancer, particularly hepatocellular carcinoma (HCC). His landmark 2024 study, which has already garnered 14 citations, provides critical evidence comparing robotic versus laparoscopic liver resection through a rigorous propensity score-matched retrospective cohort analysis. This work addresses a significant gap in the literature regarding long-term outcomes of these two approaches for HCC patients. Dr. Yang’s major contributions lie in establishing safety and efficacy benchmarks for robotic liver surgery, helping to guide clinical decision-making in complex oncologic resections. His research has direct implications for improving surgical precision, reducing recovery times, and enhancing patient outcomes in liver cancer treatment. By systematically evaluating these advanced surgical modalities, Dr. Yang is shaping the future of hepatobiliary surgery and providing surgeons with evidence-based guidance for selecting the optimal minimally invasive approach. His work continues to influence both clinical practice and ongoing research in surgical oncology.

Research Focus

Key Achievements

1
H-Index
1
Papers
14
Total Citations
14
Avg Citations/Paper
🏆 Most Cited Paper
Efficacy and safety of robotic versus laparoscopic liver resection for hepatocellular carcinoma: a propensity score-matched retrospective cohort study
14 citations · 2024
📈 Most Prolific Year: 2024 (1 Papers)
🤝 Key Collaborators: 18
🏛 Institutions: Chinese PLA General Hospital

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 11 days ago